Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00950040 · ClinicalTrials.gov registry record · NA
Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT00950040 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 92 participants.
The verdict
NCT00950040, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
This study is designed to test an intervention to reduce at-risk drinking among Type 2 diabetic patients. At-risk drinking is associated with inferior diabetes treatment adherence and control. The investigators hypothesize that our brief alcohol intervention will result in a reduction in drinking and better diabetes treatment adherence and control. If successful, this intervention could help diabetics to gain better control of their diabetes and live healthier lives.
Interventions
- BEHAVIORAL General health education
- BEHAVIORAL Brief alcohol intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2009-07 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00950040
The ClinicalTrials.gov registry entry for NCT00950040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General health education is the first listed.
NCT00950040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00950040 about?
NCT00950040 is a clinical study titled "Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics". This study is designed to test an intervention to reduce at-risk drinking among Type 2 diabetic patients. At-risk drinking is associated with inferior diabetes treatment adherence and control. The investigators hypothesize that our brief alcohol intervention will result in a reduction in drinking an...
What is the current status of trial NCT00950040?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2009-07. Estimated completion is 2017-03.
What interventions are being tested in trial NCT00950040?
The interventions under investigation include: General health education (BEHAVIORAL), Brief alcohol intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00950040?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.